Cimpress had its Relative Strength (RS) Rating upgraded from 68 to 73 Thursday — a welcome improvement, but still below the 80 or higher score you look for.
Can You Really Time The Stock Market?
IBD's unique RS Rating measures technical performance by using a 1 (worst) to 99 (best) score that identifies how a stock's price performance over the last 52 weeks compares to other publicly traded companies.
History reveals that the stocks that go on to make the biggest gains tend to have an RS Rating north of 80 in the early stages of their moves. See if Cimpress can continue to show renewed price strength and hit that benchmark.
Cimpress is not currently showing a potential entry point. See if the stock goes on to build a promising consolidation that could kick off a new price move.
The company posted 0% EPS growth last quarter. Revenue increased 4%.
The company holds the No. 5 rank among its peers in the Commercial Services-Document Management industry group. Pitney Bowes is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
